Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study-Reference-Cited by-同舟云学术

Therapeutic vaccine BRII-179 restores HBV-specific immune responses in patients with chronic HBV in a phase Ib/IIa study

Published:2021-12 Issue:6 Volume:3 Page:100361
ISSN:2589-5559
Container-title:JHEP Reports
language:en
Short-container-title:JHEP Reports

Author:

Ma Haiyan^ORCID,Lim Tien Huey,Leerapun Apinya,Weltman Martin,Jia Jidong^ORCID,Lim Young-suk^ORCID,Tangkijvanich Pisit,Sukeepaisarnjaroen Wattana^ORCID,Ji Yun^ORCID,Le Bert Nina,Li Dong^ORCID,Zhang Yao,Hamatake Robert^ORCID,Tan Nicole^ORCID,Li Chunming^ORCID,Strasser Simone I.,Ding Huiguo^ORCID,Yoon Jung-Hwan,Stace Nigel H.,Ahmed Tanvir,Anderson Dave E.,Yan Li,Bertoletti Antonio^ORCID,Zhu Qing,Yuen Man-Fung

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology,Immunology and Allergy,Internal Medicine

Reference22 articles.

1. A brief history of hepatitis milestones;Trepo;Liver Int,2014

2. The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013;Stanaway;Lancet,2016

3. Therapeutic strategies for hepatitis B virus infection: towards a cure;Fanning;Nat Rev Drug Discov,2019

4. Interferon treatment for hepatitis B;Konerman;Clin Liver Dis,2016

5. Adaptive immunity in HBV infection;Bertoletti;J Hepatol,2016

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B;Annals of Hepatology;2025-01

2. Canadian Association for the Study of the Liver Single Topic Conference on Hepatitis B Virus: ‘Progress toward hepatitis B elimination in Canada’;Canadian Liver Journal;2024-08-28

3. Current trends and advances in antiviral therapy for chronic hepatitis B;Chinese Medical Journal;2024-06-28

4. Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections;Antiviral Research;2024-06

5. Therapeutic vaccine-induced plasma cell differentiation is defective in the presence of persistently high HBsAg levels;Journal of Hepatology;2024-05